SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)

CUSIP: P8696W104

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Shares, par value US$0.001 per share
Shares outstanding
71,872,133
Total 13F shares
654,395
Share change
+338,809
Total reported value
$4,040,321
Price per share
$6.47
Number of holders
13
Value change
+$1,998,321
Number of buys
12

Quarterly Holders Quick Answers

What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Vivo Capital, LLC
13F
Company
8.2%
5,900,000
 $615,369,410 — 31 Mar 2023
13F
ORBIMED ADVISORS LLC
13F
Company
3.8%
2,718,735
 $340,000,000 — 31 Mar 2023
13F
Neumann Advisory Hong Kong Ltd
13F
Company
0.44%
315,586
 $2,042,000 — 31 Mar 2023
13F

Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q2 2023

As of 30 Jun 2023, SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 654,395 shares. The largest 10 holders included Neumann Advisory Hong Kong Ltd, STATE STREET CORP, Yorktown Management & Research Co Inc, Skandinaviska Enskilda Banken AB (publ), GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, MORGAN STANLEY, JPMORGAN CHASE & CO, and WELLS FARGO & COMPANY/MN. This page lists 13 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
3
Q2 2023 holders
13
Holder diff
10
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .